K.‐A. Kreuzer

Preexistence and evolution of imatinib mesylate-resistant clones in chronic myelogenous leukemia detected by a PNA-based PCR clamping technique

K.‐A. Kreuzer, Philipp le Coutre, Olfert Landt et al. · Annals of Hematology · 2003 · 87 citations

Hematological Malignancy, Chromatin, Imatinib Mesylate-resistant Clones +9

Inadequate Erythropoietin Response to Anaemia in HIV Patients: Relationship to Serum Levels of Tumour Necrosis Factor‐Alpha, Interleukin‐6 and Their Soluble receptors

K.‐A. Kreuzer, JU ̈RGEN KURT ROCKSTROH, Wolfgang Jelkmann et al. · British Journal of Haematology · 1997 · 55 citations

Immunodeficiencies, Immunology, Immune Regulation +18

Prophylaxis of infectious complications with colony-stimulating factors in adult cancer patients undergoing chemotherapy—evidence-based guidelines from the Infectious Diseases Working Party AGIHO of the German Society for Haematology and Medical Oncology (DGHO)

Jörg Janne Vehreschild, Angelika Böhme, Oliver A. Cornely et al. · Annals of Oncology · 2014 · 45 citations · Full text

Oncology, Preventive Medicine, Antibiotics +9

VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 4‐YEAR FOLLOW‐UP ANALYSIS OF THE RANDOMIZED CLL14 STUDY

Othman Al‐Sawaf, C. Zhang, Sandra Robrecht et al. · Hematological Oncology · 2021 · 14 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Cll14 Study +15

Combined administration of imatinib mesylate and ionizing radiation leads to increased radiosensitivity in the human glioblastoma cell line RuSi RS1

Matthias Holdhoff, K.‐A. Kreuzer, C. Appelt et al. · Journal of Clinical Oncology · 2004 · 13 citations

Engineering, Radiation Effect, Radiation Exposure +22